Glasgow, UK: Tissue Solutions introduces additions to their extensive range of cellular products. Available immediately is their portfolio of human iPS-derived cell types which are conveniently already differentiated and ready to use. Some of the benefits of our human iPS cells are listed below:

  • Our Induced Pluripotent Stem (iPS) cell lines are always immediately available for delivery.
  • Our iPS-derived cells are already differentiated saving your company time and valuable resources.
  • iPS cell lines are accurate and effective disease models and prove useful in neurological disease studies such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease. 


The current range includes the following reprogrammed from human iPS-derived multipotent progenitor cells:

  • Human iPS-derived Microglia (Ready-to-Ship vials)
  • Human iPS-derived Neural Progenitor Cells
  • Human iPS-derived Astrocytes
  • Human iPS-derived Oligodendrocyte Progenitor Cells (OPCs)
  • Human iPS-derived Cortical Neurons
  • Human iPS-derived Sensory Neurons
  • Human iPS-derived Dopaminergic Neurons
  • Human iPS-derived Melanocytes
  • Human iPS-derived Keratinocytes

 
If you would like any further details please do not hesitate to contact Jodie either by email at jodie@tissue-solutions.com or by phone on +44(0) 141 299 0055.